NATIONAL BOARD OF EXAMINATIONS
JUNE 2020
SURGICAL ONCOLOGY
PAPER-I
--- Content provided by FirstRanker.com ---
Time: 3 hoursSURGONCO/J/20/47/I
Max. Marks:100
Important Instructions:
Attempt al questions in order.
--- Content provided by FirstRanker.com ---
Each question carries 10 marks.Read the question careful y and answer to the point neatly and legibly.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer al the parts of a single question together.
--- Content provided by FirstRanker.com ---
Start the answer to a question on a fresh page or leave adequate space between two answers.Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1. a) Briefly explain microbiota.
5+(3+2)
--- Content provided by FirstRanker.com ---
b) Enumerate the role of microbiota on.i. Etiology of cancers.
i . Chemotherapy and immunotherapy.
2.
What is mismatch repair? What are the genes involved in MMR 2+2+3+3
--- Content provided by FirstRanker.com ---
deficiency? How does mismatch repair deficiency contribute to genomicinstability? Outline the clinical application of MMR deficiency.
3.
What is meant by immune surveil ance? Outline the mechanism of
2+4+4
--- Content provided by FirstRanker.com ---
action of checkpoint inhibitors and their clinical application.4.
a) Discuss the current controversies in breast cancer screening.
5+5
b) Role of MRI in the screening and fol ow up of breast cancer.
--- Content provided by FirstRanker.com ---
5.a) Role of indocyanine green in oncology.
5+5
b) Role of minimal y invasive surgery in gastric cancer.
6.
--- Content provided by FirstRanker.com ---
a) Types and mechanism of cancer angiogenesis.5+5
b) Epithelial to mesenchymal transition.
7.
a) Oncological significance of Programmed Death-Ligand 1(PDL1)
--- Content provided by FirstRanker.com ---
5+5protein.
b) Discuss the role of PDL 1 blockage in three malignancies, with
evidence.
8.
--- Content provided by FirstRanker.com ---
a) Anastomotic complications in esophageal surgery.5+5
b) Prevention and management of thoracic duct injury on esophageal
surgery.
9.
--- Content provided by FirstRanker.com ---
a) What are the various targeted mutation analysis methods used in5+3+2
oncology?
b) What is Sangers Sequencing?
c) FISH.
--- Content provided by FirstRanker.com ---
10. Define Apoptosis. Outline the mechanism of apoptosis and its clinical2+(4+4)
application.
************
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
--- Content provided by FirstRanker.com ---
EXAMINATION HALL.